WE HELP FOUNDERS BUILD TRANSFORMATIVE DIGITAL HEALTH COMPANIES

Transforming the healthcare industry through clinical and economic insights,
adherence and healthcare outcomes

A groundbreaking liquid biopsy test to screen for early-stage cancer and disease

 

Rewriting DNA synthesis to endless possibilities

Reify develops modern technologies that create a more transparent, predictable clinical trial experience for sponsors and allows healthcare providers to more seamlessly integrate clinical trials into the clinical care of patients

 

Hormone health brand guiding people through their lifelong hormone journey

Globally providing immediate healthcare access for a happier, healthier, longer life

A trailblazer in digital health, revolutionizing chronic condition management to help transform lives.

AMV is the leading early-stage venture capital firm investing in digital health

AMV Updates

CONTRIBUTED: TRIALS AND TRIBULATIONS - THE NEW WORLD OF DECENTRALIZED TRIALS

Skip Fleshman
MobiHealthNews
January 22, 2021

During the COVID-19 pandemic, pharma companies have had to improvise on how they think about setting up, administering and monitoring trials. New digital health entrants are helping manage these changes, and a few new trends are emerging. The most prominent is the use of technology that enables trial participants to accomplish their regimen remotely from clinical trial sites.

CNBC POWER LUNCH

Five digital health trends investors are watching in 2017

Skip Fleshman
MobiHealthNews
Feb 16, 2017

The healthcare market is enormous with over $3.2 trillion of annual spend in the United States in 2015, and the sector has had significant regulatory changes over the past seven years largely driven by the Affordable Care and HITECH Acts.

AMV

AMV is a venture capital firm investing in
early-stage digital health, technology and
life sciences companies.

2595 E Bayshore Rd, Suite 240
Palo Alto, CA
650.621.8808

© 2019 Asset Management Ventures
All Rights Reserved